AAAAAA

   
Results: 1-25 |
Results: 25
Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia
Authors: Vey, N Balatzentko, G LaFage, M Sainty, D Bouabdallah, R Chabannon, C Blaise, D Gastaut, JA Gabert, J
Citation: N. Vey et al., Survey of early disapearance of BCR/ABL fusion transcript after allogeneicor autologous stem cell transplantation for chronic myelogenous leukemia, LEUK LYMPH, 42(5), 2001, pp. 945-952
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials
Authors: Bouabdallah, R Stoppa, AM Coso, D Bardou, VJ Blaise, D Chabannon, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials, ANN ONCOL, 12(4), 2001, pp. 513-517
Forced expression of the Ikaros 6 isoform in human placental blood CD34(+)cells impairs their ability to differentiate toward the B-lymphoid lineage
Authors: Tonnelle, C Bardin, F Maroc, C Imbert, AM Campa, F Dalloul, A Schmitt, C Chabannon, C
Citation: C. Tonnelle et al., Forced expression of the Ikaros 6 isoform in human placental blood CD34(+)cells impairs their ability to differentiate toward the B-lymphoid lineage, BLOOD, 98(9), 2001, pp. 2673-2680
Detection of epithelial cells in hematopoietic organs of patients with breast cancer - Physiopathological significance and clinical consequences
Authors: Chabannon, C Olivero, S Viret, F Arnoulet, C Sainty, D Maraninchi, D Viens, P
Citation: C. Chabannon et al., Detection of epithelial cells in hematopoietic organs of patients with breast cancer - Physiopathological significance and clinical consequences, ACT HAEMAT, 105(3), 2001, pp. 166-171
CD34(+) immunoselected cells for poor graft function following allogeneic BMT
Authors: Mohty, M Faucher, C Chabannon, C Vey, N Stoppa, AM Ladaique, P Novakovitch, G Olivero, S Bouabdallah, R Gastaut, JA Maraninchi, D Blaise, D
Citation: M. Mohty et al., CD34(+) immunoselected cells for poor graft function following allogeneic BMT, CYTOTHERAPY, 2(5), 2000, pp. 367-370
Ex vivo expansion of human hematopoietic progenitors and cells to support high-dose chemoradiation therapy: Five years of clinical experience
Authors: Chabannon, C Olivero, S Blaise, D Maraninchi, D Viens, P
Citation: C. Chabannon et al., Ex vivo expansion of human hematopoietic progenitors and cells to support high-dose chemoradiation therapy: Five years of clinical experience, CYTOK CELL, 6(2), 2000, pp. 97-108
The relationships between public research and the biotechnology industry: appropriate American model European countries?
Authors: Orsi, F Moatti, JP Eisinger, F Chabannon, C
Citation: F. Orsi et al., The relationships between public research and the biotechnology industry: appropriate American model European countries?, M S-MED SCI, 16(1), 2000, pp. 94-100
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation
Authors: Mohty, M Faucher, C Vey, N Stoppa, AM Viret, F Chabbert, I Chabannon, C Bouabdallah, R Ladaique, P Collet, L Zandotti, C Maraninchi, D Baise, D
Citation: M. Mohty et al., High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation, BONE MAR TR, 26(3), 2000, pp. 251-255
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study
Authors: Genre, D Viens, P Gravis, G Bertucci, F Cowen, D Novakovitch, G Dermeche, S Chabannon, C Oziel-Taieb, S Camerlo, J Houvenaeghel, G Jacquemier, J Maraninchi, D
Citation: D. Genre et al., Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study, ANTICANC R, 20(3B), 2000, pp. 2033-2040
Rescue of haemopoiesis by a combination of growth factors including stem-cell factor
Authors: Blaise, D Faucher, C Vey, N Caraux, J Maraninchi, D Chabannon, C
Citation: D. Blaise et al., Rescue of haemopoiesis by a combination of growth factors including stem-cell factor, LANCET, 356(9238), 2000, pp. 1325-1326
Metabolic effects of photodynamically induced apoptosis in an erythroleukemic cell line. A P-31 NMR spectroscopic study of Victoria-Blue-BO-sensitized TF-1 cells
Authors: Viola, A Lutz, NW Maroc, C Chabannon, C Julliard, M Cozzone, PJ
Citation: A. Viola et al., Metabolic effects of photodynamically induced apoptosis in an erythroleukemic cell line. A P-31 NMR spectroscopic study of Victoria-Blue-BO-sensitized TF-1 cells, INT J CANC, 85(5), 2000, pp. 733-739
Detection of different Ikaros isoforms in human leukaemias using real-timequantitative polymerase chain reaction
Authors: Olivero, S Maroc, C Beillard, E Gabert, J Nietfeld, W Chabannon, C Tonnelle, C
Citation: S. Olivero et al., Detection of different Ikaros isoforms in human leukaemias using real-timequantitative polymerase chain reaction, BR J HAEM, 110(4), 2000, pp. 826-830
T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselectionof CD34(+) cells
Authors: Olivero, S Novakovitch, G Ladaique, P Sainty, D Viret, F Faucher, C Stoppa, AM Blaise, D Chabannon, C
Citation: S. Olivero et al., T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselectionof CD34(+) cells, CYTOTHERAPY, 1(6), 1999, pp. 469-477
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell (R) technology
Authors: Chabannon, C Novakovitch, G Blache, JL Olivero, S Camerlo, J Genre, D Maraninchi, D Viens, P
Citation: C. Chabannon et al., The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell (R) technology, HEM CELL TH, 41(2), 1999, pp. 78-81
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement
Authors: Viret, F Blaise, D Bouabdallah, R Stoppa, AM Novakovitch, G Faucher, C Vey, N Camerlo, J Oziel-Taieb, S Ladaique, P Gastaut, JA Maraninchi, D Chabannon, C
Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-dosesof cyclophosphamide
Authors: Chabannon, C Blache, JL Sielleur, I Douville, J Faucher, C Gravis, G Arnoulet, C Oziel-Taieb, S Blaise, D Novakovitch, G Camerlo, J Chabbert, I Genre, D Appel, M Armstrong, D Maraninchi, D Viens, P
Citation: C. Chabannon et al., Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-dosesof cyclophosphamide, INT J ONCOL, 15(3), 1999, pp. 511-518
beta-Galactosidase marker genes to tag and track human hematopoietic cells
Authors: Bagnis, C Chabannon, C Mannoni, P
Citation: C. Bagnis et al., beta-Galactosidase marker genes to tag and track human hematopoietic cells, CANC GENE T, 6(1), 1999, pp. 3-13
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
Authors: Bouabdallah, R Stoppa, AM Rossi, JF Lepeu, G Coso, D Xerri, L Ladaique, P Chabannon, C Blaise, D Bardou, VJ Alzieu, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
Ex vivo manipulations alter the reconstitution potential of mobilized human CD34(+) peripheral blood progenitors
Authors: Humeau, L Namikawa, R Bardin, F Mannoni, P Roncarolo, MG Chabannon, C
Citation: L. Humeau et al., Ex vivo manipulations alter the reconstitution potential of mobilized human CD34(+) peripheral blood progenitors, LEUKEMIA, 13(3), 1999, pp. 438-452
Transplantation of allogeneic CD34(+) blood cells in leukemia or lymphoma patients at high risk of GVHD
Authors: Viret, F Chabannon, C Aurran-Schleinitz, T Reviron, D Stoppa, AM Faucher, C Ladaique, P Gastaut, JA Maraninchi, D Blaise, D
Citation: F. Viret et al., Transplantation of allogeneic CD34(+) blood cells in leukemia or lymphoma patients at high risk of GVHD, BONE MAR TR, 24(2), 1999, pp. 225-227
CD34(+) cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol
Authors: Olivero, S Alario, T Ladaique, P Haccoun, M Viens, P Blaise, D Chabannon, C
Citation: S. Olivero et al., CD34(+) cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol, BONE MAR TR, 23(4), 1999, pp. 387-394
Optimization of peripheral blood stem cell collection by leukopheresis - Interaction between economic and clinical assessment of an innovation
Authors: Le Corroller, AG Moatti, JP Chabannon, C Faucher, C Fortanier, C Ladaique, P Blache, JL Novakovitch, G Maraninchi, D Blaise, D
Citation: Ag. Le Corroller et al., Optimization of peripheral blood stem cell collection by leukopheresis - Interaction between economic and clinical assessment of an innovation, INT J TE A, 15(1), 1999, pp. 161-172
Early progenitor cells from human mobilized peripheral blood express low levels of the flt3 receptor, but exhibit various biological responses to flt3-L
Authors: Aurran-Schleinitz, T Imbert, AM Humeau, L Bardin, F Charbord, P Chabannon, C
Citation: T. Aurran-schleinitz et al., Early progenitor cells from human mobilized peripheral blood express low levels of the flt3 receptor, but exhibit various biological responses to flt3-L, BR J HAEM, 106(2), 1999, pp. 357-367
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study
Authors: Blaise, D Jourdan, E Michallet, M Jouet, JP Boiron, JM Michel, G Faucher, C Fegueux, N Schuller, MP Badri, N Chabannon, C Maraninchi, D
Citation: D. Blaise et al., Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study, BONE MAR TR, 22(12), 1998, pp. 1153-1158
Marking human hematopoietic progenitors and T lymphocytes with beta-galactosidase genes
Authors: Bagnis, C Chabannon, C Mannoni, P
Citation: C. Bagnis et al., Marking human hematopoietic progenitors and T lymphocytes with beta-galactosidase genes, RESEARCH IN, 1998, pp. 403-426
Risultati: 1-25 |